JP2006514284A - 羊水内環境の非侵襲性評価 - Google Patents

羊水内環境の非侵襲性評価 Download PDF

Info

Publication number
JP2006514284A
JP2006514284A JP2004568314A JP2004568314A JP2006514284A JP 2006514284 A JP2006514284 A JP 2006514284A JP 2004568314 A JP2004568314 A JP 2004568314A JP 2004568314 A JP2004568314 A JP 2004568314A JP 2006514284 A JP2006514284 A JP 2006514284A
Authority
JP
Japan
Prior art keywords
sample
vaginal
treatment
intraamniotic
biomarkers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004568314A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006514284A5 (enExample
Inventor
イリーナ エー． ブーヒムッシ，
ロバート クリストナー，
カタリン エス． ブーヒムッシ，
カール ピー． ウェイナー，
Original Assignee
サイファージェン バイオシステムズ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サイファージェン バイオシステムズ インコーポレイテッド filed Critical サイファージェン バイオシステムズ インコーポレイテッド
Publication of JP2006514284A publication Critical patent/JP2006514284A/ja
Publication of JP2006514284A5 publication Critical patent/JP2006514284A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/471—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4745—Insulin-like growth factor binding protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/5752—Placental lactogen; Chorionic Somatomammotropin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/5756—Prolactin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70539—MHC-molecules, e.g. HLA-molecules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
JP2004568314A 2003-02-05 2003-11-13 羊水内環境の非侵襲性評価 Withdrawn JP2006514284A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44497603P 2003-02-05 2003-02-05
PCT/US2003/036118 WO2004072638A1 (en) 2003-02-05 2003-11-13 Non-invasive assessment of intra-amniotic environment

Publications (2)

Publication Number Publication Date
JP2006514284A true JP2006514284A (ja) 2006-04-27
JP2006514284A5 JP2006514284A5 (enExample) 2007-01-11

Family

ID=32869302

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004568314A Withdrawn JP2006514284A (ja) 2003-02-05 2003-11-13 羊水内環境の非侵襲性評価

Country Status (5)

Country Link
US (1) US20060240495A1 (enExample)
EP (1) EP1590664A4 (enExample)
JP (1) JP2006514284A (enExample)
AU (1) AU2003290773A1 (enExample)
WO (1) WO2004072638A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013512434A (ja) * 2009-11-25 2013-04-11 ホロジック，インコーポレイテッド 羊膜内感染の検出
JP2013527467A (ja) * 2010-06-03 2013-06-27 ビオシネクス 胎膜破水検出の方法

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
US8068990B2 (en) 2003-03-25 2011-11-29 Hologic, Inc. Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
EP1756554A4 (en) * 2004-06-03 2009-04-29 Vermillion Inc BIOMARKERS FOR PERIPHERAL ARTERY DISEASE
EP2982761B1 (en) * 2006-01-04 2017-10-04 Fujirebio America, Inc. Use of he4 and other biochemical markers for assessment of endometrial and uterine cancers
US9892475B1 (en) 2006-11-03 2018-02-13 E&C Medical Intelligence, Inc. System and method for interactive clinical support and compliance with clinical standards and guidelines in real-time
KR101142434B1 (ko) * 2011-09-08 2012-05-08 (주)오비메드 조기양막파수 산모에서 비침습적인 양수 내 염증 및 감염의 예측 또는 진단 방법
US9797903B2 (en) 2012-10-24 2017-10-24 Winthrop-University Hospital Non-invasive biomarker to identify subject at risk of preterm delivery
TWI502067B (zh) * 2013-12-10 2015-10-01 Nat Univ Tsing Hua 臨床檢體採樣器具及其方法
US20160349235A1 (en) * 2015-05-26 2016-12-01 Joshua A. Bornhorst System and Method for Analysis of Protein Migration in Serum Protein Electrophoresis
US20200264188A1 (en) 2017-09-13 2020-08-20 Progenity, Inc. Preeclampsia biomarkers and related systems and methods
EP4031004A1 (en) * 2019-09-22 2022-07-27 Ecole Polytechnique Federale De Lausanne (Epfl) Device and method for pre-term birth risk assessment
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. ASSESSMENT OF PREECAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR ASSAYS
CN120352556B (zh) * 2025-06-18 2025-08-26 江南大学附属医院 一种胎膜早破智能检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281522A (en) * 1988-09-15 1994-01-25 Adeza Biomedical Corporation Reagents and kits for determination of fetal fibronectin in a vaginal sample
US6017693A (en) * 1994-03-14 2000-01-25 University Of Washington Identification of nucleotides, amino acids, or carbohydrates by mass spectrometry
US6140099A (en) * 1994-05-20 2000-10-31 The Trustees Of The University Of Pennsylvania Method of delaying fetal membrane rupture by inhibiting matrix metalloproteinase-9 activity
US5641636A (en) * 1994-05-20 1997-06-24 University Of Pennsylvania Method of predicting fetal membrane rupture based on matrix metalloproteinase-9 activity

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013512434A (ja) * 2009-11-25 2013-04-11 ホロジック，インコーポレイテッド 羊膜内感染の検出
JP2015232567A (ja) * 2009-11-25 2015-12-24 ホロジック, インコーポレイテッドHologic, Inc. 羊膜内感染の検出
JP2013527467A (ja) * 2010-06-03 2013-06-27 ビオシネクス 胎膜破水検出の方法

Also Published As

Publication number Publication date
EP1590664A4 (en) 2007-05-23
US20060240495A1 (en) 2006-10-26
AU2003290773A8 (en) 2004-09-06
AU2003290773A1 (en) 2004-09-06
WO2004072638A8 (en) 2005-06-23
WO2004072638A1 (en) 2004-08-26
EP1590664A1 (en) 2005-11-02

Similar Documents

Publication Publication Date Title
US12339288B2 (en) Multi-protein biomarker assay for brain injury detection and outcome
JP2006514284A (ja) 羊水内環境の非侵襲性評価
US20060127962A1 (en) Biomarkers for intro-amniotic inflammation
EP0663071B1 (en) Method for prediction of premature labor
JP2013512434A (ja) 羊膜内感染の検出
JP2009524829A (ja) ヒトｉｖｆ由来胚のプロテオームフィンガープリンティング：発生能のバイオマーカーの同定法
AU2009279809A1 (en) Multiplexed diagnostic test for preterm labor
US20060257946A1 (en) Serum biomarkers in ischaemic heart disease
JP2010522882A (ja) 卵巣癌のバイオマーカー
US20140147874A1 (en) Biomarkers of cardiac ischemia
CN101223445A (zh) 乳腺癌的生物标志
WO2005093413A2 (en) Diagnosis and treatment of preeclampsia
CN115452521A (zh) 用于肝棘球蚴病鉴别的标志物、产品及系统
US20250035650A1 (en) Biomarker testing for chronic persistent injury following brain trauma
US20110008903A1 (en) Methods and kits for determining the occurrence of a liver disease in a subject
RU2586412C2 (ru) Способ оценки риска возникновения патологии беременности
WO2009100327A2 (en) Methods of diagnosing chronic prostatitis/chronic pelvic pain syndrome
WO2025243332A1 (en) Lfa device for detecting biomarkers for intrapartum and neonatal complications and method thereof
CN120847397A (zh) 尿液外泌体组织蛋白酶d在2型糖尿病肾病诊疗中的应用
KR20220055152A (ko) 급성 융모양막염 진단용 조성물 및 이를 이용한 급성 융모양막염 진단방법
Neprasova et al. Research Article Toward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study
JP2008064677A (ja) ネフローゼ症候群の疾患関連たんぱく質およびその使用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20061113

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061113

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20061220